This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Alphatec Spine Postpones 2013 Annual Meeting Of Stockholders To June 21, 2013 And Supplements Proxy Statement

CARLSBAD, Calif., June 11, 2013 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets physician-inspired solutions for patients with spinal disorders, today announced that it has postponed its 2013 Annual Meeting of Stockholders, originally scheduled for Monday, June 17, 2013. The Annual Meeting will now take place on Friday, June 21, 2013, at 2:00 P.M., Pacific Time at the Company's corporate headquarters, which are located at 5818 El Camino Real, Carlsbad, CA 92008.

The Company also announced that it has supplemented its Proxy Statement for the 2013 Annual Meeting to add a new proposal to approve an amendment to the Alphatec Holdings, Inc. Amended and Restated 2005 Employee, Director and Consultant Stock Plan to increase the per person annual award limit contained in the Plan from 200,000 shares to 1,500,000 shares per year and to provide additional disclosure with respect to certain other proposals in the Proxy Statement. The Company postponed the Annual Meeting in order to provide additional time for stockholders to review the additional proposal and revised disclosures.

Formal notice of the rescheduled meeting, the Supplement to the Company's Proxy Statement and new proxy cards are being mailed to the Company's stockholders. More information on the Annual Meeting can be found in the Company's Proxy Statement and the Supplement thereto, which are available in the "Financial Information" section of the "Investor Relations" section of the Company's website at , and on the website of the U.S. Securities and Exchange Commission at .

The record date for the Annual Meeting has not changed as a result of the change in the meeting date. Stockholders of record at the close of business on April 23, 2013 are entitled to notice of, and to vote at, the 2013 Annual Meeting and any adjournment or postponement of the meeting. Stockholders are encouraged to vote by telephone, the Internet or mail prior to the Annual Meeting, whether or not they plan to attend the meeting. Stockholders who wish to vote on the new proposal or change their votes on the other proposals must submit a new proxy and will revoke all prior proxies by doing so. See the information in the Company's Proxy Statement and the Supplement thereto regarding voting procedures.

About Alphatec Spine

Alphatec Spine, Inc., a wholly owned subsidiary of Alphatec Holdings, Inc., is a medical device company that designs, develops, manufactures and markets physician-inspired products and solutions for the treatment of spinal disorders associated with trauma, congenital deformities, disease and degeneration. The Company's mission is to combine innovative surgical solutions with world-class customer service to improve outcomes and patient quality of life. The Company and its affiliates market products in the U.S. and in over 50 countries internationally via a direct sales force and independent distributors. Additional information can be found at .
CONTACT: Investor/Media Contact:
         Mark Francois
         Senior Director, Investor Relations
         Alphatec Spine, Inc.
         (760) 494-6610

Alphatec Spine

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.65 -0.66%
FB $101.93 0.92%
GOOG $681.92 -0.32%
TSLA $150.47 4.73%
YHOO $26.75 -1.30%


Chart of I:DJI
DOW 15,660.18 -254.56 -1.60%
S&P 500 1,829.08 -22.78 -1.23%
NASDAQ 4,266.8370 -16.7550 -0.39%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs